Stomach Cancer Trial, Recruiting NCT07250347 Sponsor: The First Affiliated Hospital with Nanjing Medical University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07250347
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with stomach (gastric) cancer confirmed by a tissue sample analysis
  • People who had a CT scan with contrast dye done before their surgery
  • People who showed no signs of cancer having spread to other parts of the body at the time of initial staging
  • People who had surgery with the goal of fully removing the cancer, and who have complete results from the tissue analysis done after surgery

Who may not be able to join:

  • People who received any treatment (such as chemotherapy or radiation) before their surgery
  • People whose pre-surgery CT scan was unclear, incomplete, or too poor in quality to be properly assessed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zhang Yudong, The First Affiliated Hospital with Nanjing Medical University

Phone: +8618251966069

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
30 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic performance of the AI model for staging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov